Chu F - Search Results

1

The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor.

Rebbaa A, Chu F, Sudha T, Gallati C, Dier U, Dyskin E, Yalcin M, Bianchini C, Shaker O, Mousa SA. Rebbaa A, et al. Among authors: chu f. Anticancer Res. 2009 Nov;29(11):4473-81. Anticancer Res. 2009. Retraction in: Anticancer Res. 2023 Oct;43(10):4780. doi: 10.21873/anticanres.16674 PMID: 20032394 Free article. Retracted.

2

Role of the proteolytic hierarchy between cathepsin L, cathepsin D and caspase-3 in regulation of cellular susceptibility to apoptosis and autophagy.

Zheng X, Chu F, Mirkin BL, Sudha T, Mousa SA, Rebbaa A. Zheng X, et al. Among authors: chu f. Biochim Biophys Acta. 2008 Dec;1783(12):2294-300. doi: 10.1016/j.bbamcr.2008.07.027. Epub 2008 Aug 13. Biochim Biophys Acta. 2008. PMID: 18775751 Free article.

3

Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.

Zheng X, Chu F, Chou PM, Gallati C, Dier U, Mirkin BL, Mousa SA, Rebbaa A. Zheng X, et al. Among authors: chu f. Am J Physiol Cell Physiol. 2009 Jan;296(1):C65-74. doi: 10.1152/ajpcell.00082.2008. Epub 2008 Oct 29. Am J Physiol Cell Physiol. 2009. PMID: 18971393 Free PMC article.

4

Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.

Rebbaa A, Chu F, Davis FB, Davis PJ, Mousa SA. Rebbaa A, et al. Among authors: chu f. Angiogenesis. 2008;11(3):269-76. doi: 10.1007/s10456-008-9110-8. Epub 2008 Apr 4. Angiogenesis. 2008. PMID: 18386142

5

Cellular conditioning with trichostatin A enhances the anti-stress response through up-regulation of HDAC4 and down-regulation of the IGF/Akt pathway.

Chu F, Chou P, Mirkin BL, Mousa SA, Rebbaa A. Chu F, et al. Aging Cell. 2008 Aug;7(4):516-25. doi: 10.1111/j.1474-9726.2008.00403.x. Epub 2008 Jul 8. Aging Cell. 2008. PMID: 18489729 Free PMC article.

6

Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

Chu F, Chou PM, Zheng X, Mirkin BL, Rebbaa A. Chu F, et al. Cancer Res. 2005 Nov 15;65(22):10183-7. doi: 10.1158/0008-5472.CAN-05-2002. Cancer Res. 2005. PMID: 16288004

7

Identification of midkine as a mediator for intercellular transfer of drug resistance.

Mirkin BL, Clark S, Zheng X, Chu F, White BD, Greene M, Rebbaa A. Mirkin BL, et al. Among authors: chu f. Oncogene. 2005 Jul 21;24(31):4965-74. doi: 10.1038/sj.onc.1208671. Oncogene. 2005. PMID: 15897897

8

The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis.

Rebbaa A, Zheng X, Chu F, Mirkin BL. Rebbaa A, et al. Among authors: chu f. Cell Death Differ. 2006 Nov;13(11):1960-7. doi: 10.1038/sj.cdd.4401895. Epub 2006 Mar 24. Cell Death Differ. 2006. PMID: 16557274

9

Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.

Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV. Chu F, et al. Cancer Res. 2005 Jun 15;65(12):5301-9. doi: 10.1158/0008-5472.CAN-04-3270. Cancer Res. 2005. PMID: 15958577

10

Mesenchymal change and drug resistance in neuroblastoma.

Naiditch JA, Jie C, Lautz TB, Yu S, Clark S, Voronov D, Chu F, Madonna MB. Naiditch JA, et al. Among authors: chu f. J Surg Res. 2015 Jan;193(1):279-88. doi: 10.1016/j.jss.2014.07.018. Epub 2014 Jul 16. J Surg Res. 2015. PMID: 25128389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,898 results

Search Page

Filters